NEVIRAPINE (NEVIRAPINE) — FDA Approval ANDA205921 (MYLAN LABS LTD)
NEVIRAPINE (NEVIRAPINE) — FDA Approval ANDA205921 (MYLAN LABS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NEVIRAPINE; Active ingredients: NEVIRAPINE; Application number: ANDA205921.
| Brand name | NEVIRAPINE |
|---|---|
| Active ingredients | NEVIRAPINE |
| Application number | ANDA205921 |
| Sponsor | MYLAN LABS LTD |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | None (Tentative Approval) |
| Products in application | 1 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →